Merial Animal Health has launched Locatim, an oral antibody supplement to aid calf scour management.
Manufactured from the colostrum of high health status cows that are hyper-immunised against E.coli, rotavirus and coronavirus, Locatim contains a guaranteed concentration of specific antibodies to enterotoxic E.coli F5 (K99).
Merial says that when given alongside the dam’s colostrum, Locatim provides enhanced protection against infection, reducing calf mortality due to neonatal diarrhoea caused by E.coli F5 (K99), and helping to protect calf health during the critical rearing period.
According to the company, a single 60ml oral dose provides direct transfer of these specific antibodies, giving local protection within the digestive tract and systemic protection following absorption through the intestinal mucosa.
For optimal absorption Locatim should be administered during the first four hours of life, but it can be given up to 12 hours after birth.
Locatim can be administered to every calf born during an outbreak of scour; at times of peak calving, when environmental challenge is high; or it can be used to enhance protection in individual calves identified as being at high risk of disease due to factors such as dystocia, weakness or the poor quality of the dam’s colostrum.
For information on purchasing stock contact your local Merial Animal Health territory manager.
MMI seeks to address mental health and wellbeing issues within the veterinary profession, while the Doctors’ Support Network provides peer support for doctors and medical students with mental health concerns.
&me was launched this time last year at the Palace of Westminster at an event sponsored by Kevan Jones MP (Labour, North Durham,) who has spoken about his own experiences with depression.
Overall eleven &me ambassadors have volunteered their own stories with mental ill-health:
A number of &me ambassadors will be taking part in an ‘&me live’ session at BSAVA Congress, from 5-8 April 2018 in Birmingham, providing a short overview of their story before taking questions from the audience. The session will take place from 8.30 to 10.10am on Saturday 7 April and will be open to all those attending Congress.
Lizzie Lockett, RCVS CEO and Mind Matters Director, said: "The feedback our &me ambassadors have received is truly heartening.
"Steve Carter, for example, had both an ex-student and colleague comment on his story thanking him for all he’s done, while a Facebook post about Rob Pettitt reached nearly 25,000 people.
"The campaign highlights how it is possible to recover from mental ill-health and flourish in your career, with the aim of encouraging those at the start of their mental ill-health experience to seek appropriate help, whether that is something profession-specific, such as Vetlife or DSN, or their GP."
Louise Freeman, Co-Chair of the DSN, added: "Many healthcare professionals face similar pressures that can lead to mental ill-health, including long hours, intense pressure, and the nature of the job which requires practitioners to constantly provide care for others, without necessarily recognising the need for self-care at the same time.
"A recurring theme that we’ve seen from these ambassadors’ stories has been that they drew on support from friends and family, and we really hope that this campaign encourages other professionals to seek help if they feel they are struggling."
The campaign is interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill-health.
To participate in the campaign, email Dr Louise Freeman on vicechair@dsn.org.uk.
Further information about the ‘&me’ campaign can be found at www.vetmindmatters.org/&me, and a blog by Louise, 'Me and #AndMe', can be found at www.vetmindmatters.org/me-and-andme/.
At this year’s event, sessions include ‘Backyard pigs – Notifiable Diseases and Zoonosis’, and a discussion on the role of paraprofessionals in the sector led by Simon Hall, APHA’s Director for EU Exit and Trade.
Drop-in Q&A sessions, workshops offering practical advice and guidance on the revalidation process and a strong focus on the Cymorth TB programme in Wales also feature.
The conference programme includes dedicated lecture streams aimed at large animal, small animal and equine practitioners and, with more than 8,000 OVs due to revalidate their qualifications in March 2019, Improve says lecture content has been tailored to cover areas of key relevance for them.
An exhibition of products and services for OV’s runs alongside the conference.
APHA’s recently appointed Veterinary Director, Dr Andrew Soldan (pictured right), said: "Having recently taken on the role of Veterinary Director for APHA, I am very much looking forward to meeting up with our OV’s and exploring some of the key challenges facing us all, as we seek to control animal disease threats at home and from abroad."
David Babington MRCVS, Business Development Director at Improve International, said: "This conference has established itself as an annual fixture in the OV diary and it remains the only event dedicated to their needs. This year’s packed programme will again highlight the growing importance of OV’s, particularly as we look ahead to the post-Brexit era."
For more information on the Official Veterinarian Conference and Exhibition or to register visit: www.officialvet.com
There were two charges against Dr Mulvey. The first was that, between May and October 2018, she failed to provide the clinical history for an English Cocker Spaniel named Henry to the Tremain Veterinary Group, despite numerous requests. Also, that between August 2018 and October 2018, she failed to respond adequately or at all to Henry’s owner's requests for information, particularly his clinical records and details of insurance claims made for Henry by her practice.
The second charge was that in January/February 2019, she failed to respond to reasonable requests from the RCVS, particularly in relation to her treatment of Henry, her continuing professional development (CPD) and the status of her Professional Indemnity Insurance.
At the beginning of the hearing, Dr Mulvey admitted the facts and conduct alleged in the charges and also admitted that when her conduct was considered cumulatively, she was guilty of disgraceful conduct in a professional respect.
The Committee, having considered the evidence provided by the College and Dr Mulvey’s admissions found all the facts and conduct to be proved.
The Committee also concluded that Dr Mulvey's failure to respond to Henry's owners and to the College amounted to disgraceful conduct both when considered individually and cumulatively.
In respect of the first charge, the Committee decided that Dr Mulvey had breached the Code of Professional Conduct for Veterinary Surgeons by failing to provide clinical records or details of insurance claims.
This was an administrative part of the function of a veterinary surgeon’s role and that failure to provide clients with such information was unacceptable and fell far short of acceptable professional standards. The Committee noted that Dr Mulvey’s failure to provide details of insurance claims had occurred because she had not made those claims, despite offering to do so.
With regard to the second charge, the Committee concluded that Dr Mulvey’s failure to respond to five requests from the College for information about Henry was unacceptable.
The Committee also considered that the omissions took place in the context of Dr Mulvey’s previous Disciplinary Committee hearing in April 2018 during which she agreed to a number of undertakings including supervision on her professional practice by an appointed supervisor. It therefore decided that her failure to provide evidence of her CPD and Professional Indemnity Insurance to the College each individually amounted disgraceful conduct in a professional respect.
The Committee then went on to consider the sanction for Dr Mulvey in relation to the both charges that it had found proved and also in respect of the charges it had found proved at its earlier hearing on 26 April 2018 for which sanction had been postponed for a period of 1 year to enable Dr Mulvey to comply with undertakings she gave to the Committee to ensure that her practice met RCVS Core Standards by May 2019.
The Committee heard from Mr Stuart King MRCVS who had been appointed to act as a Workplace Supervisor for Dr Mulvey during the period of her Undertakings. Mr King provided the Committee with a report upon the extent to which Dr Mulvey had complied with the terms of her undertakings including the extent which she had implemented Dr King’s numerous recommendations.
The Committee also heard from Dr Byrne MRCVS an inspector for the RCVS’s voluntary Practice Standards Scheme that Dr Mulvey’s practice, when inspected by him in early April 2019, had not met RCVS PSS Core standards in a number of areas.
The Committee heard from Dr Mulvey and her Counsel that she accepted that she had not met RCVS Core standards as she had undertaken to do.
In reaching its decision as to sanction for all the matters, the Committee took into account that Dr Mulvey’s misconduct overall was serious because it was repeated.
The Committee also considered aggravating and mitigating factors.
Aggravating factors included the fact that the misconduct was sustained or repeated over a period of time (in relation to charge 1 for a period of approximately 4 months and in relation to charge 2 for approximately 6 weeks).
Other aggravating factors include the fact that Dr Mulvey’s conduct contravened advice issued by the Professional Conduct Department in letters sent to her, and that she had wilfully disregarded the role of the RCVS and the systems that regulate the veterinary profession.
Mitigating factors included that: there was no harm to any animal; there was no financial gain for Dr Mulvey or any other party; there was no ulterior motive behind Dr Mulvey’s conduct; and that Dr Mulvey had in fact both completed her minimum CPD requirement and secured Professional Indemnity Insurance, demonstrating that she had not attempted to hide such information from the College.
It also took into account that Dr Mulvey, prior to the first Disciplinary Committee’s hearing in 2018, worked without any previous disciplinary findings against her from 1976 to 2018. The Committee also noted that she had made efforts to comply with some of the undertakings.
Mr Ian Green, Chair of the DC and speaking on behalf of the Disciplinary Committee, said: "The Committee considered that a warning or reprimand was not an appropriate sanction that would meet the public interest. Instead, the Committee decided that a suspension order for a period of six months would allow Dr Mulvey sufficient time to focus on ensuring her practice met the Core Standards set out in the Practice Standards Scheme, without the daily demands of practising as a veterinary surgeon, and was a proportionate and sufficient sanction to meet the public interest.
"The Committee was satisfied that a period of six months met the public interest as it was sanctioning Dr Mulvey for two sets of similar misconduct which we had determined overall as serious. The Committee also believed that during these six months Dr Mulvey could reflect and reorganise her practice, and there would be little risk to animals and the public in her returning to practice."
Dr Mulvey has 28 days from being informed of the Committee’s decision to lodge an appeal with the Privy Council.
Interestingly, the survey of 2000 people found that men were 11% more likely than women to change their veterinary surgery if they didn't like the look of the masks. There were also geographical variations in the levels of concern about masks, with Londoners (48%) and people from the South West (46%), the North East (41%) and the West Midlands (41%) being most concerned.
Still, there is some consolation for any practice that is using sub standard masks: 78% of UK adults wouldn’t know how to tell if a face mask was fake.
However, 26% of respondents said they would ask their vet to prove their medical grade face mask meets the certified standard and 22% of pet owners said they would expect their vet to wear a medical grade face mask during routine checkups for the foreseeable future.
James Kinsella, Director at Bluetree Group, said: “During such an unprecedented time, it’s no surprise that people are worried about the use of face masks. It is clear that the public has strong feelings about the quality of face masks in practices, with a third of pet owners saying they are worried about the standard of their vet’s face mask. It’s encouraging to see that where expectations are not met, people will seek an alternative.
"The majority of people admit they would not be able to identify a fake face mask, however it is encouraging that a third of those we spoke to would have the confidence to take action and change their vet if they didn’t think their face mask was up to standard."
For more information on Bluetree Group’s face masks, visit: https://bluetreemaskbox.co.uk.
The intranasal vaccine can be administered to calves from one week old. It reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V).
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life, and claims the vaccine delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. Duration of immunity is 12 weeks for both viruses.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: "Having this early life calf pneumonia vaccine available in single dose vials will give farmers more practical leeway to be able to vaccinate vulnerable young calves from as young as a week of age, rather than delaying administration until a batch of calves are available. We know that early-age protection of young calves through intranasal vaccination can help prevent pneumonia and positively impact a beef or dairy calf’s productive future".
The new single dose vials are supplied in packs of five, complementing the five dose vials already available.
For further information, contact your MSD account manager.
Last year Petplan received over 31,000 nominations across the five award categories: Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year.
The awards are judged by an independent panel which narrows the field to three finalists in each category, who are then invited to attend the awards ceremony.
The judges are looking for examples of exceptional levels of animal care, building and sustaining great relationships with colleagues and pet owners, and those who have gone above and beyond the call of duty.
James Barnes, Head of Sales & Partnerships at Petplan, said: “The Petplan Veterinary Awards provide the perfect opportunity to say thank you for the exceptional work carried out by members of the veterinary profession, whatever their field and wherever they’re based. The Petplan Vet Awards provide a great opportunity for both clients and colleagues to recognise the dedication and talent of veterinary professionals, teams and practices, right across the UK and say a particular thank you to those who have kept up the exceptional level of care even in the midst of a global crisis."
To nominate a colleague or your practice, visit www.petplan.co.uk before nominations close on 10th January 2022.
The Swadlincote and Melbourne-based IVC practice worked with a Great Workplaces by BVA accreditor during the pilot of the new scheme, to demonstrate its strengths against an accreditation framework covering four key themes: health and wellbeing, leadership and management, culture and learning and development.
In the report, the accreditor was particularly impressed by the practice’s strong leadership and management; its emphasis on accommodating flexibility for team members in various forms; a robust teamworking ethos; and a focus on continuous improvement.
British Veterinary Association President Elizabeth Mullineaux said: “We’re delighted to see Swadlincote Veterinary Centre become the first veterinary workplace to achieve Gold accreditation through Great Workplaces by BVA scheme.
"Congratulations to the whole practice team for this incredible recognition.
“Creating positive working environments and targeting areas for improvement are the key to tackling ongoing workforce challenges around recruitment and retention.
"We hope this first Gold accreditation inspires others to strive towards gaining recognition as workplaces where vet teams thrive.”
Ingrid Stevenson, Clinical Director at Swadlincote Veterinary Centre, said: “While we knew the practice was doing well, we didn’t go into this process expecting Gold at all.
"My practice manager and I were just both really keen to get some feedback and to find out what more we could do to help the team.
“We have several clinical accreditations in the practice, but it is the team that are responsible for achieving these and maintaining the high standards.
"I believe the team should be looked after, recognised and rewarded for their hard work and going above and beyond when necessary.
"The team were really pleased when I shared the news.
"It has certainly been good for team morale and a positive outcome to share with potential new recruits. '
“The accreditation process was a thorough assessment of the practice and our accreditor made us feel all at ease during the interviews.
"While we achieved Gold, which was unexpected, we have also learnt of areas to develop further over the coming months.
"Overall, it was a positive experience for our practice.”
www.bva.co.uk/take-action/good-veterinary-workplaces/
Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.
Dechra says it expects Osphos to change the way chronic lameness caused by navicular syndrome is tackled by equine vets.
According to the company, clinical trials of Osphos showed 74.7% of horses experienced improvement by at least one lameness grade at 56 days post treatment.
Dechra brand manager Emma Jennings said: "Osphos intramuscular injection contains the bisphosphonate clodronic acid which inhibits resorption in the navicular bone by binding to hydroxyapatite crystals and by direct cellular effects on osteoclasts.
"We are delighted with the results of the trials, which proved that Osphos is effective at 6 months post-treatment. We're looking forward to being able to support equine vets, vet nurses and practices by providing an intramuscular Clodronic acid injection for horses."
Dechra also says studies showed that mild transient colic was seen following just 1.6 per cent of treatments.
Osphos 60 mg/ml solution for injection for horses is available from September 2014.
Matt Yarnall from Boehringer Ingelheim said: "This is fantastic news for Bovela which offers a truly unique and innovative way of controlling BVD in a herd, something that is now clearly being appreciated by farmers and vets alike."
The company says over 5 million doses of Bovela have now been sold across Europe2 showing how quickly farmers have understood the benefits of a single dose vaccine that provides a full 12 months of live vaccine protection.
Matt added: "Feedback we have from vets and farmers throughout Europe shows two main things. Firstly, for those who haven’t controlled BVD before, there is the realisation of how much better herd health can be and secondly, for those who have previously struggled with multiple primary course vaccines or those that should be boosted every six months, there is relief at Bovela’s easy-to-follow regime."
References
The company's new van has a range of 146 miles before it needs recharging, and it can be recharged to 80% within 40 minutes.
That puts 60% of MWI's customers within range of its distribution centre in Stoke-on-Trent, including those in Manchester and Birmingham.
As part of its drive to establish more sustainable operations, MWI has also launched a pilot with one of its corporate customers in which they reduce the number of deliveries made per week – adopting a two or three-day a week delivery system.
The company says that since January, that has resulted in 700,000 fewer vehicle miles.
MSD says the new license claim means the vaccine combines the broadest calf scour protection available with unique user convenience.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: “When correctly administered as a single 2ml intramuscular dose to pregnant cattle 12-3 weeks prior to calving, Bovilis Rotavec Corona boosts antibodies in colostrum for rotavirus, coronavirus and now both E.coli F5 (K99) and F41.
"Calves gain protection against these infectious scour pathogens by drinking the fortified colostrum from their vaccinated mothers.
“Bovilis Rotavec Corona also contains the most prevalent rotavirus strain in Europe2, which minimises the chances of a calf scour protection breakdown due to differences between vaccine antigens and the ubiquitous antigens on farm3.”
Kat added: "Vet, RAMA and farmer feedback suggests the wide vaccination window (12-3 weeks pre-calving) and the fact that an opened bottle of vaccine lasts for up to 28 days are particularly useful practical benefits in a mix of both dairy and beef suckler systems.”
Bovilis Rotavec Corona is available in 5, 20 and 50-dose packs from both veterinary professionals and the agricultural merchant trade.
Dechra Veterinary Products has launched an online CPD programme to help the veterinary profession diagnose, manage and treat dogs suffering from Hyperadrenocorticism (Cushing's syndrome).
The new Canine Hyperadrenocorticism CPD module has been designed to help vets by providing them with a comprehensive overview of the condition, which they can study in their own time and at their own pace. According to Dechra, it aims to take the guesswork out of managing this complex condition and to support vets in improving the quality of life of Cushing's syndrome patients.
It is the latest online CPD course to be offered through The Dechra Academy, a resource which offers a range of learning and support content and client materials. Accounting for six hours' CPD, the Cushing's syndrome online module complements a CPD road show on the disease recently completed by Dechra around the UK. Over 350 vets attended the sessions and further meetings are scheduled for later in 2011.
Greg Williams, Veterinary Technical Services Manager, said: "Cushing's syndrome remains a challenge to the profession because the clinical signs can easily be confused with those of other disorders and tests results are not always clear cut. We know from the strong attendance at our road show earlier this year that there is a real hunger in the profession to build stronger understanding of the disease.
"Through The Dechra Academy, we bring together the latest thinking on a range of clinical conditions and provide practical, up to the minute training, tips, tools and case studies to help vets spread best practice across their clinical and nursing staff. We also offer CPD in a range of formats - face to face, online and video - to ensure we can accommodate the needs of even the busiest practice.
"We're delighted to launch this new module on Cushing's syndrome and know that it will prove to be a useful tool for vets in practice."
For further information on The Dechra Academy or Cushing's syndrome CPD, please contact your Territory Manager, ring Dechra on 01939 211200 or visit www.dechra.co.uk/academy.
Dechra Veterinary Products Ltd is part of Dechra Pharmaceuticals PLC ('Dechra') and offers a range of pharmaceutical products and instruments to veterinary practices in the UK. The company specialises in the development and marketing of licensed branded pharmaceuticals and specialist premium pet foods for companion animals in the global veterinary market. Dechra is committed to developing new products and services that support the work of veterinary professionals and enhance the lives of their patients and also to investing in products and added-value services that deliver its promise to support veterinary professionals and pet owners.
The company says that the packs have been redesigned to make it easier for pet owners to identify the variety of products available.
The new packaging has stronger imagery, simplified and larger product names to improve readability, and kibble shapes displayed actual size to reassure owners of smaller breeds that it will be suitable for their pet. Flavour profiles and breed sizes are displayed on all packs.
Hill's says the new range is also presented in optimised bag sizes for more convenient feeding. Small and Miniature and Mini dog foods have been combined into a new Small & Mini product, designed to cover the needs of all small dogs under 10kg.
For more information, visit: https://www.hillspet.co.uk/science-plan/new-look.
The new facility will have 9 consultation rooms and 4 theatres, and is expected to open in early 2022.
It will be Animal Trust’s 10th veterinary hospital – with existing locations in Wrexham, Yorkshire and North England.
Animal Trust now employs more than 300 vets and veterinary care staff.
A further 15 jobs will be created in Rhyl when the new hospital opens.
Owen said: “Our ethos has always been that every animal deserves access to experienced and professional veterinary care as soon as they become ill.
"That’s why we offer free consultations for sick and injured animals brought to our surgeries.
"Our clients are from all walks of life and they come to us because of what we stand for and in some cases, for the prices we offer.
“As a CIC, we try and make sure that a comprehensive veterinary service is within reach of as many pet owners as possible.
"We build large veterinary hospitals that will serve the needs of the local pet-owning community and make a positive impact on their lives.
"Our new surgery will allow us to extend our services to the residents of the North Wales coastline, many of whom currently have to travel to one of our other existing surgeries.”
Funding for Animal Trust was provided by the £500 million Wales Flexible Investment Fund.
Following the outcry from the profession over the disciplinary hearing into Mr M Chikosi, the RCVS' new Operational Board has clarified the the College's position on the use of blankets to move animals.
The hearing found Munhuwepasi Chikosi guilty of unreasonably delaying attending a dog that had been run over at a farm, and of unnecessarily causing her to remain in pain and suffering for at least an hour.
As a result, the Disciplinary Committee directed that Mr Chikosi's name be removed from the Register for serious professional misconduct. The College says that since the appeal window has closed without an appeal being made, Mr Chikosi has now been struck off.
However, the Committee also said: "... his [Mr Chikosi's] advice that Mitzi should be moved on a blanket was wrong, as she may have had an injured back."
This was widely criticised as being out of touch with the practicalities of real life and unsupported by any evidence.
Speaking on behalf of the Board, President Neil Smith said: "We fully support the decision taken by the independent Disciplinary Committee with regard to the Chikosi hearing, with one comment requiring clarification: the issue of whether a blanket can be used to move an injured dog. We consider that it is acceptable, in most cases, to transport an injured dog with the aid of a blanket.
"The profession should be reassured that our Standards Committee [the new name for Advisory Committee] will consider the general issues raised by the Chikosi hearing at its next meeting. This will not be a review of the decision, but form part of the routine consideration of DC hearings made by the Committee to see if they raise issues that require additional guidance and advice."
Dechra Veterinary Products has launched Sporimune (ciclosporin), licensed for the treatment of chronic manifestations of atopic dermatitis in dogs.
Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "Around 20% of all small animal consultations involve skin conditions and canine atopic dermatitis can be challenging to diagnose and manage effectively.
"Although incurable, atopic dermatitis can be managed using a multimodal approach which is likely to include treatments to decrease pruritus as well as allergen identification, avoidance where possible and improving skin and coat hygiene."
Sporimune is a 50 mg/ml oral solution administered by syringe, which is graduated to show both bodyweight and ml. Dechra says it is being introduced to veterinary professionals within the company's Partners in Practice programme which aims to support vets and vet nurses as they diagnose, control and maintain complex dermatological conditions.
Mr Brown added: "It is critical that owners are fully involved and educated about their pet's condition for dogs to be treated effectively. So we have also developed support materials around the use of Sporimune for practices, including client information leaflets and a video on how to use the dosing syringe."
Sporimune is now available from veterinary wholesalers. For further information visit www.dechra.co.uk/sporimune.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and due to be validated by Harper Adams University, Improve says the new Cert will be delivered over 14 modules in three blocks of training by globally recognised experts in practical training centres in Sheffield, UK; Cremona, Italy and Madrid, Spain.
The modules will be supported by an online learning platform providing notes, additional learning resources and the ability for delegates to discuss clinical cases in a closed forum.
David Babington MRCVS, Business Development Director at Improve International, said: "Our GPAdvCert in Small Animal Soft Tissue Surgery is a natural progression for veterinary surgeons who want to develop their soft tissue surgery skills.
"The programme focuses on problem-solving to increase confidence in diagnosing and stabilising animals with complex pathologies and delegates will have plenty of opportunity to practise new surgical techniques and advanced procedures under close supervision in a wet-lab environment."
He added: "In common with our other GPAdvCerts in Orthopaedics and Small Animal Medicine, achieving this qualification will help vets in practice to reduce the number of patients they have to refer, enabling them to retain a higher level of income for their practice. The programme will also provide them with skills which they can pass onto their team."
The GPAdvCert in Small Animal Soft Tissue Surgery is aimed at veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Surgery (GPCertSAS) or a Postgraduate Certificate (PgC) in Small Animal Surgery.
Improve says the successful achievement of a GPAdvCert enables delegates to progress from a Postgraduate Certificate (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Master’s Degree (MSc) in Advanced Veterinary Practice Sciences.
The MSD Animal Health Research Bursary for Veterinary Surgeons offers three awards, consisting of two ruminant bursaries and one companion animal bursary, of up to £4,000 each.
Each project should be completed within one to two years and the vet practitioner proposals will be judged by university academics to ensure independent assessment.
The companion animal research bursary will be assessed by the University of Nottingham Centre for Evidence-based Veterinary Medicine and the ruminant research bursary applications will be assessed by academic staff from the University of Bristol School of Veterinary Science.
Michelle Townley, veterinary advisor at MSD Animal Health (pictured right) said: "Our Vet Surgeon Research Bursaries have an important role to play in encouraging vet surgeons to continue to develop their research skills. New knowledge and good research skills form the life-blood of the industry so we’re keen to see proposals from both ruminant and companion animal practitioners. Being awarded a bursary has proved to be a career-changing experience for some participants so we’re keen to get as many applications as possible as part of our investment in the veterinary industry."
The deadline for entries is 30th November 2018. For more information, visit www.msdahresearchbursary.co.uk.
Petplan is giving away a VIP trip for two people to this year's 'Petplan Veterinary Awards' in Birmingham on 31st March.
The prize includes two admission tickets to the awards ceremony, as well as accommodation at a top hotel in Birmingham.
Veterinary staff can be in with a chance at winning this exclusive opportunity by nominating their practice or a member of staff for the following awards:
Alison Andrew, Petplan's Marketing Manager, said, "Veterinary professionals up and down the country show great commitment and dedication to our pets everyday and the awards are an opportunity to recognise all their hard work. By nominating a colleague you can not only show them your appreciation but you can also going into the draw to win a fantastic night out"
By making a nomination at www.petplan.co.uk/vetawards you'll automatically be entered into the draw to win the VIP tickets to the evening.
Nominations for the awards close on the 4th February and the winner of the VIP tickets will be announced in late February.
Under the scheme, 60 students will be given two weeks of supported clinical placements in more than 50 Vets4Pets practices across the UK, helping to prepare them for work in a clinical environment.
Successful applicants will receive £334 per week during their placements and will also have access to a fast-track application to the Vets4Pets Graduate Programme.
Emily Bridges, Vet & Graduate Programme Lead at Vets4Pets said: “While we know that great EMS placements are a key part of a student’s development, we also know that it has become increasingly difficult for students to fund EMS while they are studying.
"By launching the bursary scheme, we’re hoping to provide students with the support they need to get the most out of their placements, without the financial worry."
Jessica Windham, a veterinary graduate from the RVC, London, took part in the pilot. She said: “For me, the bursary helped to pay for my fuel and food while on placement.
"This meant I could go home and rest after eight hours in the practice, instead of going straight to my part-time bar job and working an extra four-hour shift like many students have to do.
"Ultimately because I was less tired, I performed far better as a student and learned a lot more.”
Applications will open in March 2022 for placements beginning in summer, and students can find out more at: www.vets4pets.com/ems
The consultation is open to veterinary surgeons, nurses, students, and the public.
One of the main - and most controversial - proposals in the consultation, which was unveiled by RCVS President Sue Patterson at BVA Live last week, is that the elected councils would be replaced by an independent merit-and-skills appointment-based system.
Sue discussed the main benefits of an appointment-based system at BVA Live:
Other proposed changes include:
The good governance proposals are part of the College’s overall legislative reform agenda in which it is seeking to replace the 1966 Veterinary Surgeons Act with new and more modern, flexible and forward-looking legislation, which would expand the regulatory remit of the College to encompass veterinary practice premises and paraprofessionals, while empowering veterinary nurses and creating a new fitness to practise system.
Sue said: “The current governance structure of the RCVS is set by the VSA and updating our governance systems is a vital prerequisite to getting new primary legislation, as the outdated and out-of-step nature of our current arrangements will be clear to see.
“Governance may not be the most exciting topic, but it is the foundation on which all other aspects of the College’s work rests.
"As a professional regulator with animal health and welfare at our heart, the RCVS has a duty to ensure that our arrangements best serve the public on whose behalf we are entrusted to regulate and uphold veterinary standards, while still maintaining veterinary input in all our decision-making processes.
“We believe these good governance proposals help us meet this mission, ensuring that we are bringing our governance in line with regulatory norms, while still recognising our unique role as a dual regulator and royal college.
"The proposals would also help us get the best talent with the right skillsets and experience to serve on RCVS Council, VN Council and our committees, drawing on both laypeople and the broad sweep of the veterinary professions.
“We acknowledge that there has been some disquiet over the fact that, under these proposals, we would no longer be holding the annual elections to either RCVS Council or VN Council.
"However, we believe that an independent, fair and skills-based appointment process would be a superior way of selecting the membership of RCVS Council and VN Council than the elections which, unfortunately, the vast majority of the veterinary professions do not currently engage in, and which risk creating the impression that the RCVS is some sort of representative organisation.
“We look forward to hearing the considered views of the professions and public regarding our good governance proposals and will carefully review the feedback we receive.”
Belinda Andrews-Jones RVN, current Chair of VN Council, added: “In many ways VN Council is ahead of the curve in terms of governance reform with a smaller number of members and two independently-appointed veterinary nurse members – of which I am one – as well as appointed lay members.
“I can personally vouch for the robust nature of the application and independent appointment process for VN Council and how it took into account what I had to offer to the role in terms of my skills, my knowledge and my experience.
“I would like to thank my fellow members of VN Council, including my elected peers, for their positive engagement with the good governance proposals and their recognition that these reforms aren’t about reducing scrutiny of the College or the amount of challenge to its decisions, but about improving outcomes for the public, their animals and the professions at large.”
The good governance recommendations have been drawn up on the basis of the Law Commission’s 2014 Report ‘Regulation of Health and Social Care Professionals’, the recommendations from which were adopted by the UK government as being the ‘regulatory norm’.
The College says any future appointment processes for RCVS Council and VN Council would also be based on the Professional Standards Authority’s appointment principles of merit, fairness, transparency and openness and having a process that inspires confidence.
The deadline for completing the consultation is Monday 22 July 2024.
https://www.rcvs.org.uk/news-and-views/our-consultations/ensuring-good-governance/
The College will also be presenting the proposals at a Zoom webinar called being chaired by Sue between 7pm and 8pm tomorrow evening, Tuesday 11 June 2024: https://www.eventbrite.co.uk/e/ensuring-good-governance-tickets-920243973497
The toolkit is part of a major study, the ‘Old Age Pets (OAP) research project’, recently funded by BSAVA PetSavers at the University of Liverpool.
The ACT includes an owner checklist for home triage and a leaflet which explains the more common health problems affecting aged dogs.
There's a practice waiting room poster which includes a QR code to give clients access to a digital version of the leaflet.
The leaflet recommends working through the checklist at least every six months and keeping completed versions for comparison, to monitor dogs as they age.
PetSavers says that some clients may benefit from advice and guidance from RVNs or PCAs on how to complete the checklist for the first time.
BSAVA has also curated a collection of articles, podcasts, lectures and book chapters to support veterinary professionals in caring for senior dogs: http://www.bsavalibrary.com/petsaversact.
Professor Carri Westgarth from the University of Liverpool said: “We conducted this research project kindly funded by BSAVA PetSavers in order to help owners and veterinary professionals provide great care for our loved pets as they age.
“Our investigations uncovered common physical and behavioural signs in dogs that owners observe and for which support from the veterinary practice would be beneficial.
"Our simple evidence-based checklist is designed to engage owners and importantly stimulate efficient discussion with their veterinary team.”
Free digital copies of the leaflet and poster can be downloaded here: http://www.bsavalibrary.com/content/cilgrouppetsaversact, where veterinary professionals can also request free printed copies for their practices.
https://www.bsava.com/petsavers/our-impact/citizen-science-project.
MSD Animal Health has launched Zuprevo Cattle, which contains a novel antibiotic molecule to help combat bovine respiratory disease (BRD).
Zuprevo Cattle contains the active ingredient tildipirosin (180mg/ml), a new 16-membered, tribasic macrolide unique to animal health. It is licensed for the treatment and prevention of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.
According to MSD Animal Health livestock veterinary adviser Paul Williams MRCVS, the new product works extremely quickly in the animal, as well as offering the longest duration of activity in the lungs of all the macrolide antibiotics currently on the market. He says it is also extremely convenient to use: "Zuprevo is readily absorbed by the animal, reaching peak plasma concentrations within 23 minutes of injection. Zuprevo is readily distributed around the body and reaches lung concentration well above MIC90 for all of the three BRD target pathogens within four hours of administration. In addition, it maintains lung concentration above the MIC90 for up to 28 days, which will appeal to many practitioners."
Paul says that it is Zuprevo's 16-membered, tribasic macrolide structure that allows it to deliver these significant pharmacological benefits for the management of BRD in cattle: "Zuprevo works by diffusing into the bacterial cell where its binding action inhibits protein synthesis of the bacterial ribosome. Its unique 16-membered, tribasic structure enables enhanced penetration of the bacterial cell wall, as well as having the ability to bypass some potential bacterial resistance mechanisms."
Paul says Zuprevo also offers vets and their farmer clients important practical usage advantages: "Zuprevo is an easily syringeable solution for injection available in convenient 20ml, 50ml and 100ml vial sizes to suit different usage requirements. At a dose rate of 1ml/45kg, it offers the lowest macrolide dose volume per kg of bodyweight. At 47 days, Zuprevo also has the shortest macrolide meat withdrawal period."
Further information on this new macrolide antibiotic is available from the MSD Animal Health territory managers or by calling the company's Veterinary Services Group on 01908 685685.
Avacta has announced the launch of Natural VetCare Prescribed, a new range of veterinary exclusive nutraceutical skin and joint supplements.
The range is manufactured in the UK by Natural VetCare and includes four products in total.
Avacta’s commercial manager, Hayley Booth, said: "Cani Flex is designed to support the body’s anti-inflammatory response with a powerful antioxidant formula, which rebalances the system by addressing excess free-radical build up around the joint following injury or wear and tear. Cani Flex Senior also targets joint, heart and brain health and encourages increased activity.
"With allergies becoming more and more prolific, Cani Skin and Feli Skin target one of the most complex issues facing vets and pet owners in today’s environment. The formulations are designed to resolve the body's hypersensitivity by balancing the immune response.
Hayley added: "To ensure veterinary exclusivity, the unique dispensing method has been thoroughly researched and trialed. The easy-to-feed sprinkle capsules sold in individual gold foil pouches are not for sale individually, and boxes of pouches are available direct from veterinary wholesalers only."
For more information, visit avactaanimalhealth.com/NVCPrescribed, contact your Avacta territory manager or call customer services on 0800 8494 550.